Trials / Conditions / Gammopathy, Monoclonal
Gammopathy, Monoclonal
5 registered clinical trials studyying Gammopathy, Monoclonal — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, NCT05573802 | Hellenic Society of Hematology | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumuma NCT05581875 | Hellenic Society of Hematology | Phase 1 / Phase 2 |
| Unknown | A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumuma NCT05280275 | Hellenic Society of Hematology | Phase 1 / Phase 2 |
| Completed | Monoclonal Gammopathy With Clinical Significance in Patients With and Without Haematological Malignancies in F NCT06559579 | University Hospital, Brest | — |
| Active Not Recruiting | Rifaximin in Patients With Monoclonal Gammopathy NCT03820817 | Emory University | Phase 1 |